Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5676125 | American Journal of Obstetrics and Gynecology | 2016 | 34 Pages |
Abstract
Uterine fibroids have a high content of collagen that can be effectively digested by highly purified collagenase C histolyticum, resulting in reduced tissue stiffness. Loss of stiffness may decrease bulk symptoms in vivo and possibly lead to shrinkage of fibroids through changed mechanotransduction, leading ultimately to reduced fibroid symptoms of pain and bleeding. Clinical trials are necessary to evaluate the safety and efficacy of collagenase C histolyticum including the rate of regrowth of fibroids. The data of this study provide a strong rationale for using this purified collagenase in clinical trials as a local treatment for women with fibroids.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Friederike L. DVM, PhD, Betty BS, Franklin T. PhD, Maragatha PhD, Farshid PhD, Phyllis C. MD, PhD,